<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01518686</url>
  </required_header>
  <id_info>
    <org_study_id>217/2006 local review board</org_study_id>
    <nct_id>NCT01518686</nct_id>
  </id_info>
  <brief_title>Age-related Normative Values for the Octopus 900 Perimeter</brief_title>
  <acronym>Norm-Oct900</acronym>
  <official_title>Normal Values for the Full Visual Field, Corrected for Age- and Reaction Time, Using Semi-automated Kinetic Testing on the Octopus 900 Perimeter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Haag-Streit AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine normal values of the visual field (VF), corrected&#xD;
      for age- and reaction time (RT) using the Octopus 900 perimeter and semi-automated kinetic&#xD;
      perimetry (SKP).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of the full Visual Field using semi-automated kinetic perimetry.</measure>
    <time_frame>one day</time_frame>
    <description>additional a subgroup of 14 participants were tested at 3 separate sessions within 4 weeks.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>one arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>observational study, no cohort, single group of different ages</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Octopus 900 perimeter (Haag Streit AG, Koeniz, Switzerland)</intervention_name>
    <description>We used the following six combinations of Goldmann8,1 stimulus size, stimulus luminance and angular velocity: V4e (64mm², 103', 320cd/m²) at 5°/s, III4e (4mm², 25.7', 320cd/m²) at 5°/s, I4e (0.25mm², 6.45', 320cd/m²) at 2°/s (for the assessment of the blind spot), I3e (0.25mm², 6.45', 100cd/m²) at 5°/s, I2e (0.25mm², 6.45', 32cd/m²) at 3°/s, I1e (0.25mm², 6.45', 10cd/m²) at 3°/s, I1a (0.25mm², 6.45', 4cd/m²) at 2°/s .&#xD;
The peripheral five isopters, consisting of 24 vectors (every 15° meridian), were presented in random order, while the innermost isopter (I1a) consisted of 12 vectors (every 30° meridian)</description>
    <arm_group_label>one arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  maximum spherical ametropia ± 6 Diopters (D)&#xD;
&#xD;
          -  maximum cylindrical ametropia ± 2 D&#xD;
&#xD;
          -  distant visual acuity ≥ 1.0 logMAR [20/20] for subjects up to 60 years, ≥ 0.8 logMAR&#xD;
             [20/25] for subjects from 61-70 years, ≥ 0.63 logMAR [20/30] for subjects older than&#xD;
             70 years&#xD;
&#xD;
          -  isocoria, pupil diameter &gt; 3mm&#xD;
&#xD;
          -  intraocular pressure (air pulse tonometer) ≤ 21mmHg&#xD;
&#xD;
          -  normal anterior segments&#xD;
&#xD;
          -  ocular fundus: normal appearance of the cup to disc ratio (CDR) ≤ 0.5, interocular&#xD;
             difference of CDR &lt; 0.3&#xD;
&#xD;
          -  normal macular region, vessels, and peripheral retinal examination (with undilated&#xD;
             pupils).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  amblyopia&#xD;
&#xD;
          -  strabismus&#xD;
&#xD;
          -  ocular motility disorder&#xD;
&#xD;
          -  diseases of the retina&#xD;
&#xD;
          -  glaucoma, glaucoma suspect&#xD;
&#xD;
          -  macular degeneration&#xD;
&#xD;
          -  IOP &gt; 21 mmHg&#xD;
&#xD;
          -  abnormal color vision test (ISPP - Ishihara and Standard Pseudoisochromatic Plates =&#xD;
             SPP)&#xD;
&#xD;
          -  history or findings of other neuro-ophthalmological disease&#xD;
&#xD;
          -  relevant opacities of the central refractive media (cornea, lens, vitreous body)&#xD;
&#xD;
          -  use of miotic drugs&#xD;
&#xD;
          -  intraocular surgery (except uncomplicated cataract surgery, more than three months&#xD;
             previous to testing)&#xD;
&#xD;
          -  kerato-refractive surgery (LASIK)&#xD;
&#xD;
          -  drugs influencing reaction time&#xD;
&#xD;
          -  drugs indicating severe general diseases (anti-diabetic pharmaceuticals and&#xD;
             anti-hypertensive medication were allowed for subjects older than 70 years)&#xD;
&#xD;
          -  mental diseases (for example psychosis)&#xD;
&#xD;
          -  pregnancy, nursing&#xD;
&#xD;
          -  acute infections&#xD;
&#xD;
          -  heavy smoking (&gt;10 cigarettes /day)&#xD;
&#xD;
          -  alcohol abuse&#xD;
&#xD;
          -  diabetic retinopathy&#xD;
&#xD;
          -  coronary heart disease&#xD;
&#xD;
          -  stroke&#xD;
&#xD;
          -  migraine&#xD;
&#xD;
          -  Raynaud's syndrome&#xD;
&#xD;
          -  suspected lack of compliance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Schiefer, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Ophthalmology / Institute for Ophthalmic Research, University of Tübingen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Ophthalmology / Institute for Ophthalmic Research, University of Tübingen</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>January 12, 2012</study_first_submitted>
  <study_first_submitted_qc>January 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2012</study_first_posted>
  <last_update_submitted>December 10, 2013</last_update_submitted>
  <last_update_submitted_qc>December 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Ulrich Schiefer</investigator_full_name>
    <investigator_title>Prof. Dr. med Ulrich Schiefer</investigator_title>
  </responsible_party>
  <keyword>Norm values</keyword>
  <keyword>semi-automated kinetic perimetry</keyword>
  <keyword>isopters</keyword>
  <keyword>mathematical model</keyword>
  <keyword>luminance</keyword>
  <keyword>test-retest reliability</keyword>
  <keyword>deviation</keyword>
  <keyword>age dependance</keyword>
  <keyword>different age groups</keyword>
  <keyword>Healthy subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

